Cerulean Pharma, Inc.(NASDAQ : CERU)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading CERU News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.03%||67.51||1.0%||$577.68m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.19%||373.00||2.1%||$320.06m|
|KITE||Kite Pharma, Inc.||3.14%||76.84||18.8%||$224.79m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.83%||119.26||1.6%||$202.56m|
|ESPR||Esperion Therapeutics, Inc.||-3.61%||38.94||18.7%||$173.60m|
|AUPH||Aurinia Pharmaceuticals Inc.||-4.41%||8.02||6.3%||$150.20m|
|CLVS||Clovis Oncology, Inc.||2.61%||70.32||17.5%||$142.57m|
|VRTX||Vertex Pharmaceuticals Incorporated||1.04%||89.98||2.2%||$135.11m|
Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA.